Using genetically engineered Treg-cell-specific SRC-3 KO mice, we show that disruption of Treg SRC-3 expression leads to a complete lifetime eradication of tumors in aggressive syngeneic breast and prostate cancer models. The gene discussed is NCOA3; the disease is prostate carcinoma.